# Commission Regulation (EC) No 1356/2005 of 18 August 2005 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards oxolinic acid and morantel (Text with EEA relevance), Division 2.1.7: Tetrahydropyrimides

Extent: E+W+S+N.I.

Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
Morantel
Sum of residues which may be hydrolysed to N-methyl-1,3-propanediamine and expressed as morantel equivalents
All ruminants
100 μg/kg
Muscle
100 μg/kg
Fat
800 μg/kg
Liver
200 μg/kg
Kidney
50 μg/kg
Milk

---
Source: https://www.legislation.gov.uk/eur/2005/1356/annex/division/A/division/2/division/2.1/division/2.1.7 (the official version)
Page: https://openlegislation.uk/eu-regulation-2005-1356/annex/division-A/division-2/division-2.1/division-2.1.7
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.